PharmTech LCGC Sciex Webinar 11.10
|Articles|May 26, 2010

Agilent completes Varian acquisition

Agilent Technologies has announced the completion of its acquisition of scientific-equipment maker Varian. The deal was reported to have cost Agilent approximately $1.5 billion in cash.

Agilent Technologies has announced the completion of its acquisition of scientific-equipment maker Varian. The deal was reported to have cost Agilent approximately $1.5 billion in cash.

In a statement from the company, Bill Sullivan, president and CEO said "The Varian acquisition - the largest in our company's history - furthers our evolution toward becoming a global leader in bio-analytical measurement. We're gaining tremendous talent and technology. And for our customers, this will mean a broader span of expertise, applications and products from one trusted company."

The majority of Varian's product lines will report into Agilent's Chemical Analysis Group (CAG), while some key businesses will be housed within Agilent's Life Sciences Group (LSG).

"Varian's products and applications expertise complement our offerings by providing a more complete spectroscopy, consumables and services portfolio to our customers," added Mike McMullen, Agilent senior vice president and president of CAG.

For more information visit www.agilent.com


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.